GlassScriptPhysician profile
Lennard J Kessler
NPI 1194733014
$1,700.77
in general payments reported to CMS, 2019-2025
22 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $289 · 2021: $279 · 2022: $214 · 2023: $147 · 2024: $315 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.52 | 2019-2023 | |
| Astellas Pharma US INC | $240.33 | 2023-2024 | Veozah |
| Ascend Therapeutics US, LLC | $159.60 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $154.05 | 2021-2025 | |
| Sage Therapeutics, LLC | $114.41 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $111.62 | 2019-2022 | |
| Exact Sciences Corporation | $83.01 | 2023-2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $70.70 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.91 | 2020 | |
| Eisai INC. | $48.31 | 2021 | |
| Vertical Pharmaceuticals, LLC | $43.66 | 2019 | |
| Merck Sharp & Dohme LLC | $38.46 | 2019 | |
| Allergan, INC. | $36.37 | 2020 | |
| Lupin INC. | $29.78 | 2019-2020 | |
| Mimedx Group, INC. | $29.61 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $24.33 | 2019 | |
| Myovant Sciences INC. | $23.58 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.83 | 2025 | Qelbree |
| Roche Diagnostics Corporation | $20.45 | 2021 | |
| Evofem Biosciences, INC. | $19.58 | 2021 | |
| Millicent US INC | $18.29 | 2025 | Intrarosa, Femlyv |
| Avion Pharmaceuticals | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lennard Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.